Discover how transient elastography paved the way for FibroScan® with Laurent Sandrin, Founder and Chief Technology Officer of Echosens.
Before becoming a company, Echosens was an idea. This idea has been growing from its root in Paris, within Prof. Fink’s lab. Initially, my PhD thesis paved the way for the development of transient elastography (TE), which we patented in 1999.
The idea grew as we met some passionate people that helped us see the application of TE in the food industry and later on in healthcare. The next stage of our story is when science and medicine met together at Institut Mutualiste Montsouris, as we started to explore the application of our technology to help improve patient care in hepatology.
Shortly after, FibroScan® by echosens, the first non-invasive tool to assess and monitor patients with chronic liver disease was born, and nearly two decades later, it has enabled millions of liver examinations worldwide. Though we treasure our roots and history, we are even more excited to establish partnerships with scientists, physicians and healthcare professionals that have today generated over 2,500 publications advocating and supporting the use of FibroScan®.
We wish to recognize their contributions and pioneering team spirit, as we unite to make liver assessment faster, simpler and more effective.